{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:44:28Z","timestamp":1762605868295},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1097\/jgp.0b013e3181e56d30","type":"journal-article","created":{"date-parts":[[2010,6,26]],"date-time":"2010-06-26T08:52:32Z","timestamp":1277542352000},"page":"266-273","source":"Crossref","is-referenced-by-count":7,"title":["Cholinesterase Inhibitors for Alzheimer Disease: Do They Provide More Than Symptomatic Benefits?"],"prefix":"10.1016","volume":"19","author":[{"given":"Guk-Hee","family":"Suh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Ho","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changsu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Su","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baik Seok","family":"Kee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon-Noh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Nam","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Hyuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo-Jin","family":"Go","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Seo","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Whan","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/JGP.0b013e3181e56d30_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/archneur.61.2.252","article-title":"The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial","volume":"61","author":"Raskind","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archneur.58.3.427","article-title":"Open-label, multi-center, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease","volume":"58","author":"Doody","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib3","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1159\/000079201","article-title":"Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy","volume":"18","author":"Wallin","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib4","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1176\/appi.ajp.160.11.2003","article-title":"Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease","volume":"160","author":"Krishnan","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.72.3.310","article-title":"Cholinesterase inhibitor treatment alters the natural history of Alzeimer's disease","volume":"72","author":"Lopez","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tips.2004.12.010","article-title":"A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?","volume":"26","author":"Francis","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0895-4356(99)00067-0","article-title":"Mortality from dementia in advanced age: a 5-year follow up study of incident dementia cases","volume":"52","author":"Aguero-Torres","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib8","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1046\/j.1532-5415.2001.49184.x","article-title":"Cognitive impairment and mortality in older primary care patients","volume":"49","author":"Stump","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib9","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1997.00550190066016","article-title":"Neurological and psychiatric predictors of mortality in patients with Alzheimer disease in California","volume":"54","author":"Moritz","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000068779","article-title":"Mortality in Alzheimer's disease","volume":"15","author":"Bonsignore","year":"2003","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/gps.1256","article-title":"Mortality in Alzheimer's disease: a comparative prospective Korean study in the community and nursing homes","volume":"20","author":"Suh","year":"2005","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1532-5415.2002.50005.x","article-title":"Tacrine therapy is associated with reduced mortality in nursing home residents with dementia","volume":"50","author":"Ott","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1212\/WNL.47.1.166","article-title":"Longt-term tacrine (Cognex) treatment: effects on nursing home placement and mortality","volume":"47","author":"Knopman","year":"1996","journal-title":"Neurology"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjopharm.2005.02.001","article-title":"Is donepezil therapy associated with reduced mortality in nursing home residents with dementia?","volume":"3","author":"Gasper","year":"2005","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/ageing\/afj083","article-title":"Comparative analysis of mortality in patients with Alzheimer's disease treated with done-pezil or galantamine","volume":"35","author":"L\u00f3pez-Pousa","year":"2006","journal-title":"Age Ageing"},{"issue":"suppl 1","key":"10.1097\/JGP.0b013e3181e56d30_bib16","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.jalz.2007.10.010","article-title":"We should not distinguish between symptomatic and disease-modifying treatments in Alzheimer's disease during development","volume":"4","author":"Doody","year":"2008","journal-title":"Alzheimers Demen"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib18","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D'Agostino","year":"1998","journal-title":"Stat Med"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-0447.1987.tb02906.x","article-title":"The prevalence of dementia: a quantitative integration of the literature","volume":"76","author":"Jorm","year":"1987","journal-title":"Acta Psychiatr Scan"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jalz.2007.02.001","article-title":"An estimate of the total worldwide societal costs of dementia in 2005","volume":"3","author":"Wimo","year":"2007","journal-title":"Alzheimers Dement"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1034\/j.1600-0447.2001.00210.x","article-title":"A review of the epidemiological transition in dementia\u2014cross-national comparisons of the indices related to Alzheimer's disease and vascular dementia","volume":"104","author":"Suh","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib22","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1176\/appi.ajgp.13.11.984","article-title":"Hallucinations and mortality in Alzheimer disease","volume":"13","author":"Wilson","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1097\/JGP.0b013e3181e56d30_bib23","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2105\/AJPH.88.9.1337","article-title":"Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset","volume":"88","author":"Brookmeyer","year":"1998","journal-title":"Am J Pub Health"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748112605338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748112605338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T05:23:02Z","timestamp":1544419382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748112605338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1064748112605338"],"URL":"https:\/\/doi.org\/10.1097\/jgp.0b013e3181e56d30","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}